NF2 and neoplasm: Extending beyond promoter silencing, genome-wide methylation profiling has revealed that NF2-associated VSs also exhibit extensive DNA hypomethylation, particularly in oncogenes and regulatory miRNAs, suggesting broader epigenetic dysregulation that may promote tumour development [79].